Ser414

Site Information
AsGGIRRsssMsYVD SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3198803

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	breast cancer ( 1 )
Relevant cell line - cell type - tissue:	BT-549 (breast cell) ( 1 ) , COS (fibroblast) ( 3 ) , HCC1937 (breast cell) ( 1 ) , HeLa (cervical) ( 2 ) , MCF-7 (breast cell) ( 1 ) , MDA-MB-231 (breast cell) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
2	Chen RQ, et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69, 2663-8 19276368 Curated Info
3	Wang Y, et al. (2007) Profiling signaling polarity in chemotactic cells. Proc Natl Acad Sci U S A 104, 8328-33 17494752 Curated Info